Fig. 5A shows that AKBA alone suppressed the constitutive activation of NF-κB in the pancreatic tumor tissue, and this down-modulation was enhanced in tissue obtained from animals treated with both AKBA and gemcitabine together. This evidence concerns the gene NFKB1 and pancreatic neoplasm.